Calvin Hirsch, MD
Hirsch C. In postmenopausal women with osteoporosis, romosozumab followed by alendronate reduced fractures vs alendronate alone. Ann Intern Med. 2018;168:JC3. doi: https://doi.org/10.7326/ACPJC-2018-168-2-003
Download citation file:
Published: Ann Intern Med. 2018;168(2):JC3.
Endocrine and Metabolism, Metabolic Bone Disorders.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use